IP Verse

Guide Rna With Chemical Modifications - EP3227447

The patent EP3227447 was granted to Agilent on Apr 24, 2024. The application was originally filed on Dec 3, 2015 under application number EP15866342A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3227447

AGILENT
Application Number
EP15866342A
Filing Date
Dec 3, 2015
Status
Granted And Under Opposition
Mar 22, 2024
Publication Date
Apr 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KRAUS & LEDERER PARTGMBBJan 24, 2025KRAUS & LEDERER PARTGMBBADMISSIBLE
DORRIESJan 22, 2025REITERADMISSIBLE
WUESTHOFF & WUESTHOFFJan 14, 2025WICHMANNADMISSIBLE
JAMES POOLESep 23, 2024CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (31) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2005281781
DESCRIPTIONUS2010076183
DESCRIPTIONUS2014273226
DESCRIPTIONUS2014273233
DESCRIPTIONUS5032401
DESCRIPTIONUS5607677
DESCRIPTIONUS7371580
DESCRIPTIONUS8202983
DESCRIPTIONWO2013176772
DESCRIPTIONWO2013176844
DESCRIPTIONWO2014093712
DESCRIPTIONWO2014144592
DESCRIPTIONWO2014144761
EXAMINATIONWO2015026885
EXAMINATIONWO2016164356
INTERNATIONAL-SEARCH-REPORTUS2014273226
INTERNATIONAL-SEARCH-REPORTUS2014273232
INTERNATIONAL-SEARCH-REPORTUS2014295557
INTERNATIONAL-SEARCH-REPORTWO2013142578
OPPOSITIONUS2015071889
OPPOSITIONWO2013176772
OPPOSITIONWO2014093712
OPPOSITIONWO2015026885
OPPOSITIONWO2016164356
OTHEREP3036327
OTHEREP3280803
OTHERUS10337001
OTHERUS10900034
OTHERWO2015026885
OTHERWO2016164356
SEARCHWO2014093712

Non-Patent Literature (NPL) Citations (39) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "2,6-Diaminopurine", Wikipedia, vol. 2, no. 10, doi:10.1007/BF00162350, pages 429 - 434, Wikipedia, URL: https://en.wikipedia.org/w/index.php?title=2,6-Diaminopurine&oldid=1238552159, XP093256269
OPPOSITION- CHOLLET A., KAWASHIMA E., "DNA CONTAINING THE BASE ANALOGEU 2-AMINOADENINE: PREPARATION, USE AS HYBRIDIZATION PROBES AND CLEAVAGE BY RESTRICTION ENDONUCLEASES.", Nucleic Acids Research, Oxford University Press, GB, GB , (19880111), vol. 16., no. 01., ISSN 0305-1048, pages 305 - 317., XP002024258
OPPOSITION- D22 - Supplementary materials for D1
OPPOSITION- D23 - US-10,337,001 Decision
OPPOSITION- D24 - US-10,900,034 Decision
OPPOSITION- D30 - Supplementary materials for D14
OPPOSITION- D32 - Supplementary materials for D16
OPPOSITION- Kariko Katalin; Weissman Drew, "Impacts of nucleoside modification on RNA-mediated activation of toll-like receptors", Kariko Katalin; Weissman Drew, Shizuo Akira (Editor), Ken J. Ishii (Editor), Nucleic Acids in Innate Immunity, 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA , CRC PRESS-TAYLOR & FRANCIS GROUP , (20080101), pages 171 - 188, ISBN 978-1-4200-6825-2, XP008166255
OPPOSITION- Rahdar M., Et Al., "Synthetic CRISPR RNA-Cas9-guided an effective date of genome editing in human cells", Proc Natl Acad Sci, USA., USA., pages E7110 - E7117, Proc Natl Acad Sci , (20220328), XP055905957
OPPOSITION- Alfonso Latorre, Ana Latorre, Álvaro Somoza, "Modified RNAs in CRISPR/Cas9: An Old Trick Works Again", Angewandte Chemie, Verlag Chemie, Hoboken, USA, Hoboken, USA, (20160307), vol. 55, no. 11, doi:10.1002/anie.201512002, ISSN 1433-7851, pages 3548 - 3550, XP055602216
OPPOSITION- Barbara Nawrot; Elzbieta Sochacka; Markus DÃ1⁄4chler, "tRNA structural and functional changes induced by oxidative stress", Cellular and Molecular Life Sciences, Birkhäuser-Verlag, Ba, Ba , (20110811), vol. 68, no. 24, doi:10.1007/s00018-011-0773-8, ISSN 1420-9071, pages 4023 - 4032, XP019981494
OPPOSITION- Uhlmann Eugen, Peyman Anusch, Will David W., "Antisense: Medicinal Chemistry", Encyclopedia of Cancer, Elsevier , (20020101), pages 103 - 117, doi:10.1016/B0-12-227555-1/00012-5, ISBN 978-0-12-227555-5, XP093269167
OPPOSITION- Dongbo Yu, Hannah Pendergraff, Jing Liu, Holly B. Kordasiewicz, Don w. Cleveland, Eric e. Swayze, Walt f. Lima, Stanley t. Crooke, Thazha p. Prakash, David r. Corey, "Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression", Cell, Cell Press, (20120801), vol. 150, no. 5, doi:10.1016/j.cell.2012.08.002, ISSN 00928674, pages 895 - 908, XP055166558
OPPOSITION- Nishimasu Hiroshi; Ran F. Ann; Hsu Patrick D.; Konermann Silvana; Shehata Soraya I.; Dohmae Naoshi; Ishitani Ryuichiro; Zhang Feng; Nureki Osamu , "Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA", Cell, Elsevier, Amsterdam NL, Amsterdam NL , (20140213), vol. 156, no. 5, doi:10.1016/j.cell.2014.02.001, ISSN 0092-8674, pages 935 - 949, XP028622533
OPPOSITION- Patrick d. Hsu, Eric s. Lander, Feng Zhang, "Development and Applications of CRISPR-Cas9 for Genome Engineering", Cell, Elsevier, Amsterdam NL, Amsterdam NL , (20140601), vol. 157, no. 6, doi:10.1016/j.cell.2014.05.010, ISSN 0092-8674, pages 1262 - 1278, XP055529223
OPPOSITION- John c. Burnett, John j. Rossi, "RNA-Based Therapeutics: Current Progress and Future Prospects", Chemistry & Biology, (20120101), vol. 19, no. 1, doi:10.1016/j.chembiol.2011.12.008, ISSN 10745521, pages 60 - 71, XP055087578
OPPOSITION- Glen f. Deleavey, Masad j. Damha, "Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing", Chemistry & Biology, (20120801), vol. 19, no. 8, doi:10.1016/j.chembiol.2012.07.011, ISSN 10745521, pages 937 - 954, XP055107150
OPPOSITION- Alexandra e. Briner, Paul d. Donohoue, Ahmed a. Gomaa, Kurt Selle, Euan m. Slorach, Christopher h. Nye, Rachel e. Haurwitz, Chase l. Beisel, Andrew p. May, Rodolphe Barrangou, "Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality", Molecular Cell, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20141001), vol. 56, no. 2, doi:10.1016/j.molcel.2014.09.019, ISSN 1097-2765, pages 333 - 339, XP055376592
OPPOSITION- SOUTSCHEK JUERGEN ET AL, "Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs", Nature, (20041111), vol. 432, no. 7014, doi:10.1038/nature03121, pages 173 - 178, XP002333747
OPPOSITION- Mitchell R. O’connell, Benjamin L. Oakes, Samuel H. Sternberg, Alexandra East-Seletsky, Matias Kaplan, Jennifer A. Doudna, "Programmable RNA recognition and cleavage by CRISPR/Cas9", Nature, ¬Macmillan Journals Ltd., etc.|, vol. 516, no. 7530, doi:10.1038/nature13769, ISSN 00280836, pages 263 - 266, XP055168138
OPPOSITION- Prashant Mali, John Aach, P Benjamin Stranges, Kevin M Esvelt, Mark Moosburner, Sriram Kosuri, Luhan Yang, George M Church, "CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering", Nature Biotechnology, Gale Group Inc., vol. 31, no. 9, doi:10.1038/nbt.2675, ISSN 10870156, pages 833 - 838, XP055149275
OPPOSITION- Ayal Hendel, Rasmus O Bak, Joseph T Clark, Andrew B Kennedy, Daniel E Ryan, Subhadeep Roy, Israel Steinfeld, Benjamin D Lunstad, Robert J Kaiser, Alec B Wilkens, Rosa Bacchetta, Anya Tsalenko, Douglas Dellinger, Laurakay Bruhn, Matthew H Porteus, "Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells", Nature Biotechnology, Nature Publishing Group US, New York, New York, vol. 33, no. 9, doi:10.1038/nbt.3290, ISSN 1087-0156, pages 985 - 989, XP055233915
OPPOSITION- Zhonghan Li, Rana Tariq M., "Therapeutic targeting of microRNAs: current status and future challenges", Nature Reviews Drug Discovery, Nature Publishing Group, GB, GB , (20140711), vol. 13, no. 8, doi:10.1038/nrd4359, ISSN 1474-1776, pages 622 - 638, XP055222651
OPPOSITION- Bin Li, Weiyu Zhao, Xiao Luo, Xinfu Zhang, Chenglong Li, Chunxi Zeng, Yizhou Dong, "Engineering CRISPR-Cpf1 crRNAs and mRNAs to maximize genome editing efficiency", Nature Biomedical Engineering, vol. 1, no. 5, doi:10.1038/s41551-017-0066, page 0066, XP055530506
OPPOSITION- Richard N. Threlfall, Adrian G. Torres, Angelika Krivenko, Michael J. Gait, Marvin H. Caruthers, "Synthesis and biological activity of phosphonoacetate- and thiophosphonoacetate-modified 2′-O-methyl oligoribonucleotides", Organic & Biomolecular Chemistry, Royal Society of Chemistry, (20120101), vol. 10, no. 4, doi:10.1039/C1OB06614E, ISSN 1477-0520, pages 746 - 754, XP055685123
OPPOSITION- Sharma Vivek K., Sharma Raman K., Singh Sunil K., "Antisense oligonucleotides: modifications and clinical trials", MedChemComm, Royal Society of Chemistry, United Kingdom, United Kingdom , (20140101), vol. 5, no. 10, doi:10.1039/C4MD00184B, ISSN 2040-2503, pages 1454 - 1471, XP093256273
OPPOSITION- Fritz Eckstein, "Phosphorothioates, Essential Components of Therapeutic Oligonucleotides", Nucleic Acid Therapeutics, Mary Ann Liebert, Inc. Publishers, US, US , (20141201), vol. 24, no. 6, doi:10.1089/nat.2014.0506, ISSN 2159-3337, pages 374 - 387, XP055518661
OPPOSITION- B. H. Yoo, "2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro", Nucleic Acids Research, (20040326), vol. 32, no. 6, doi:10.1093/nar/gkh516, pages 2008 - 2016, XP055156919
OPPOSITION- Zunyi Yang, Daniel Hutter, Pinpin Sheng, A. Michael Sismour, Steven A. Benner, "Artificially expanded genetic information system: a new base pair with an alternative hydrogen bonding pattern", Nucleic Acids Research, Oxford University Press, GB, GB , (20061201), vol. 34, no. 21, doi:10.1093/nar/gkl633, ISSN 0305-1048, pages 6095 - 6101, XP055729693
OPPOSITION- KRÜTZFELDT J, ET AL., "Specificity, duplex degradation and subcellular localization of antagomirs", Nucleic Acids Research, Oxford University Press, GB, GB , (20070416), vol. 35, no. 9, doi:10.1093/NAR/GKM024, ISSN 0305-1048, pages 2885 - 2892, XP002532650
OPPOSITION- Terrazas Montserrat, Kool Eric T., "RNA major groove modifications improve siRNA stability and biological activity", Nucleic Acids Research, Oxford University Press, GB, GB , (20090201), vol. 37, no. 2, doi:10.1093/nar/gkn958, ISSN 0305-1048, pages 346 - 353, XP093256279
OPPOSITION- R. Barrangou, A. Birmingham, S. Wiemann, R. L. Beijersbergen, V. Hornung, A. V. B. Smith, "Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference", Nucleic Acids Research, Information Retrieval Ltd., (20150420), vol. 43, no. 7, doi:10.1093/nar/gkv226, ISSN 03051048, pages 3407 - 3419, XP055203983
OPPOSITION- O’reilly Daniel; Kartje Zachary J; Ageely Eman A; Malek-Adamian Elise; Habibian Maryam; Schofield Annabelle; Barkau Christopher L; Rohilla Kushal J; Derossett Lauren B; Weigle Austin T; Damha Masad J; Gagnon Keith T, "Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity", Nucleic Acids Research, Oxford University Press, GB, GB , (20190101), doi:10.1093/nar/gky1214, ISSN 0305-1048, pages 1 - 13, XP055780518
OPPOSITION- M. Jinek, K. Chylinski, I. Fonfara, M. Hauer, J. A. Doudna, E. Charpentier, "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity", Science, American Association for the Advancement of Science, (20120817), vol. 337, no. 6096, doi:10.1126/science.1225829, ISSN 00368075, pages 816 - 821, XP055067740
OPPOSITION- M. Jinek, F. Jiang, D. W. Taylor, S. H. Sternberg, E. Kaya, E. Ma, C. Anders, M. Hauer, K. Zhou, S. Lin, M. Kaplan, A. T. Iavarone, E. Charpentier, E. Nogales, J. A. Doudna, "Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation", Science, American Association for the Advancement of Science, (20140314), vol. 343, no. 6176, doi:10.1126/science.1247997, ISSN 00368075, pages 1247997 - 1247997, XP055149157
OPPOSITION- R. E. Wang, H. Wu, Y. Niu, J. Cai, "Improving the Stability of Aptamers by Chemical Modification", Current medicinal chemistry, Bentham Science Publishers, (20110901), vol. 18, no. 27, doi:10.2174/092986711797189565, ISSN 09298673, pages 4126 - 4138, XP055216480
SEARCH- AYAL HENDEL ET AL, "Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells", NATURE BIOTECHNOLOGY, (20150629), vol. 33, no. 9, doi:10.1038/nbt.3290, ISSN 1087-0156, pages 985 - 989, XP055233915 [IP] 1-3,7-9,15-19 * figure 1 *
SEARCH- WULAN DENG ET AL, "CASFISH: CRISPR/Cas9-mediated in situ labeling of genomic loci in fixed cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, US, (20150831), vol. 112, no. 38, doi:10.1073/pnas.1515692112, ISSN 0027-8424, pages 11870 - 11875, XP055431540 [IP] 1-3,7-9,15-19 * page 11875 *
SEARCH- MEGHDAD RAHDAR ET AL, "Synthetic CRISPR RNA-Cas9-guided genome editing in human cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, US, (20151116), doi:10.1073/pnas.1520883112, ISSN 0027-8424, XP055264777 [IP] 1-3,7-9,15-19 * figure 3 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents